The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how generic pharmaceuticals stocks fared in Q3, starting with Viatris (NASDAQ:VTRS).
Otis has been treading water for the past six months, recording a small return of 4.2% while holding steady at $97.90.
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the apparel retailer stocks, including Torrid (NYSE:CURV) and its peers.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Uber (NYSE:UBER) and the best and worst performers in the gig economy industry.
Over the last six months, Burlington’s shares have sunk to $243.51, producing a disappointing 10.4% loss - a stark contrast to the S&P 500’s 8.9% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Since August 2024, SMART has been in a holding pattern, posting a small return of 1.2% while floating around $21. The stock also fell short of the S&P 500’s 8.9% gain during that period.
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Apple (NASDAQ:AAPL) and its peers.
Bark trades at $1.83 and has moved in lockstep with the market. Its shares have returned 6.4% over the last six months while the S&P 500 has gained 8.9%.
Over the last six months, The Real Brokerage’s shares have sunk to $5.55, producing a disappointing 9.6% loss - a stark contrast to the S&P 500’s 8.9% gain. This may have investors wondering how to approach the situation.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at discount retailer stocks, starting with Burlington (NYSE:BURL).